drugs

Amgen Second-Quarter Profit Gains on Arthritis Drug - Bloomberg
RTT NewsAmgen Second-Quarter Profit Gains on Arthritis DrugBloombergSales of Enbrel rose 7 percent to $899 million in the quarter, while revenue for Aranesp, a treatment for anemia that was once Amgen's top-selling drug, ...Amgen quarterly profit tops StreetReutersGSK link marks shift for AmgenFinancial TimesAmgen ups guidance on strong earningsPacific Coast Business TimesForbesall 193 news articles��